New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product.

The research paper is centered around the identification of a new parvovirus – Equine parvovirus-hepatitis (EqPV-H) – associated with serum hepatitis, commonly referred to as Theiler’s disease, in horses. Triggered by a biological product, tetanus antitoxin, this study explores the virus’ pathogenicity and transmissibility.

Introduction

• The research began following the death of a horse in Nebraska, USA, 65 days after treatment with an equine-origin tetanus antitoxin. The horse died from serum hepatitis, a form of Theiler’s disease—a serious, often life-threatening horse disease of unknown cause.
• The researchers suspected a link between the tetanus antitoxin and the sudden onset of the disease; thus, prompting further research.

Identification of Equine Parvovirus-Hepatitis (EqPV-H)

• The researchers discovered an unidentified parvovirus present in the serum and liver of the deceased horse and within the tetanus antitoxin administered to it.
• This newfound virus, named the “equine parvovirus-hepatitis” (EqPV-H), was found to share less than 50% protein identity with its closest genetic relatives belonging to the Copiparvovirus genus. This has led the researchers to conclude that they have found a new virus.

Experimental Infections

• Following the identification of EqPV-H, the researchers sought to confirm its pathogenicity and thus infected two horses with the same tetanus antitoxin contaminated with EqPV-H.
• As a result, both horses developed viremia (presence of viruses in the blood), experienced seroconversion (the period of time during which a specific antibody develops and becomes detectable in the blood), and developed acute hepatitis. This result was confirmed through clinical, biochemical, and histopathologic testing.

Prevalence and Transmissibility of EqPV-H

• Lastly, the scholars examined the prevalence of this new virus within the horse population; out of a sample of 100 seemingly healthy adult horses, 13 were found to be viremic and 15 were seropositive (tested positive for a particular serum antibody). This suggests that EqPV-H is an endemic infection—that is, it’s constantly present to some extent in the equine population.
• The research also suggested that EqPV-H could be transmitted through contaminated biological products, including the tetanus antitoxin used in this study.

Conclusion

• The article’s significant findings include the identification of a new virus—EqPV-H—associated with equine serum hepatitis, the verification of its pathogenicity, and the confirmation of its transmissibility through contaminated biological products.